Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Keratins are important for skin cell health and their problems can cause diseases.

Genetically modified plants could be an important source of omega-3 fats to meet global needs.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Hair loss is influenced by genetics, diet, and lifestyle, but more research is needed on nutrition's role.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Vitamin D might help regulate insulin in the body, but taking Vitamin D supplements doesn't clearly prevent or improve type 2 diabetes. More research is needed.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

A unique gene mutation causes vitamin D-resistant rickets without causing hair loss.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.